These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 18525047

  • 1. Aliskiren and dual therapy in type 2 diabetes mellitus.
    Ingelfinger JR.
    N Engl J Med; 2008 Jun 05; 358(23):2503-5. PubMed ID: 18525047
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aliskiren combined with losartan in diabetes and nephropathy.
    Anderson S, Komers R.
    N Engl J Med; 2008 Sep 04; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
    [No Abstract] [Full Text] [Related]

  • 4. [Renin inhibition and the kidney].
    Ecder T.
    Turk Kardiyol Dern Ars; 2009 Oct 04; 37 Suppl 7():28-31. PubMed ID: 20019474
    [Abstract] [Full Text] [Related]

  • 5. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M, Simioni N, Masiero A.
    Minerva Endocrinol; 2009 Dec 04; 34(4):333-8. PubMed ID: 20046162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aliskiren combined with losartan in type 2 diabetes and nephropathy.
    Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK, AVOID Study Investigators.
    N Engl J Med; 2008 Jun 05; 358(23):2433-46. PubMed ID: 18525041
    [Abstract] [Full Text] [Related]

  • 8. [Advantages and limitations of renin inhibition with aliskiren].
    Azizi M, Frank M, Steichen O, Blanchard A.
    Ann Pharm Fr; 2011 May 05; 69(3):142-50. PubMed ID: 21570538
    [Abstract] [Full Text] [Related]

  • 9. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
    López V, Martin M, Cobelo C, Aranda P, Cabello M, Sola E, Gutierrez C, Burgos D, Martínez D, Hernandez D.
    Transplant Proc; 2010 Oct 05; 42(8):2883-5. PubMed ID: 20970559
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr 05; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 12. Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.
    Doulton TW, MacGregor GA.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec 05; 10(4):185-9. PubMed ID: 19617273
    [Abstract] [Full Text] [Related]

  • 13. [The future of renin inhibition].
    Uresin AY, Baran E.
    Turk Kardiyol Dern Ars; 2009 Oct 05; 37 Suppl 7():32-8. PubMed ID: 20019475
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renin inhibition in hypertension.
    Gradman AH, Kad R.
    J Am Coll Cardiol; 2008 Feb 05; 51(5):519-28. PubMed ID: 18237679
    [Abstract] [Full Text] [Related]

  • 16. [What is renin inhibition? Mechanism of action].
    Timurkaynak T.
    Turk Kardiyol Dern Ars; 2009 Oct 05; 37 Suppl 7():5-14. PubMed ID: 20019471
    [Abstract] [Full Text] [Related]

  • 17. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.
    Nephrol Dial Transplant; 2009 May 05; 24(5):1663-71. PubMed ID: 19145003
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Renin as a target of direct pharmacological block in arterial hypertension].
    Mukhin NA, Fomin VV.
    Ter Arkh; 2009 May 05; 81(8):5-9. PubMed ID: 19799192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.